BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10807736)

  • 1. Doxazosin inhibits retinoblastoma protein phosphorylation and G(1)-->S transition in human coronary smooth muscle cells.
    Kintscher U; Wakino S; Kim S; Jackson SM; Fleck E; Hsueh WA; Law RE
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1216-24. PubMed ID: 10807736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoids inhibit proliferation of human coronary smooth muscle cells by modulating cell cycle regulators.
    Wakino S; Kintscher U; Kim S; Jackson S; Yin F; Nagpal S; Chandraratna RA; Hsueh WA; Law RE
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):746-51. PubMed ID: 11348869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
    Blaschke F; Leppanen O; Takata Y; Caglayan E; Liu J; Fishbein MC; Kappert K; Nakayama KI; Collins AR; Fleck E; Hsueh WA; Law RE; Bruemmer D
    Circ Res; 2004 Dec; 95(12):e110-23. PubMed ID: 15539633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mitogenic signaling and induction of apoptosis in human bladder smooth muscle cells treated with doxazosin.
    Austin PF; Cook BL; Niederhoff RA; Manson SR; Coplen DE; Weintraub SJ
    J Urol; 2004 Oct; 172(4 Pt 2):1662-5; discussion 1666. PubMed ID: 15371785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-thiazolidinedione partial peroxisome proliferator-activated receptor gamma ligand inhibits vascular smooth muscle cell growth.
    Bruemmer D; Berger JP; Liu J; Kintscher U; Wakino S; Fleck E; Moller DE; Law RE
    Eur J Pharmacol; 2003 Apr; 466(3):225-34. PubMed ID: 12694805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest.
    Srethapakdi M; Liu F; Tavorath R; Rosen N
    Cancer Res; 2000 Jul; 60(14):3940-6. PubMed ID: 10919672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation.
    Schoecklmann HO; Rupprecht HD; Zauner I; Sterzel RB
    Kidney Int; 1997 Apr; 51(4):1228-36. PubMed ID: 9083291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
    Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-Phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation.
    Leng X; Connell-Crowley L; Goodrich D; Harper JW
    Curr Biol; 1997 Sep; 7(9):709-12. PubMed ID: 9285720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-gamma inhibits human airway smooth muscle cell proliferation by modulating the E2F-1/Rb pathway.
    Amrani Y; Tliba O; Choubey D; Huang CD; Krymskaya VP; Eszterhas A; Lazaar AL; Panettieri RA
    Am J Physiol Lung Cell Mol Physiol; 2003 Jun; 284(6):L1063-71. PubMed ID: 12588705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor alpha inhibits cyclin A expression and retinoblastoma hyperphosphorylation triggered by insulin-like growth factor-I induction of new E2F-1 synthesis.
    Shen WH; Yin Y; Broussard SR; McCusker RH; Freund GG; Dantzer R; Kelley KW
    J Biol Chem; 2004 Feb; 279(9):7438-46. PubMed ID: 14681231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells.
    Wakino S; Kintscher U; Kim S; Yin F; Hsueh WA; Law RE
    J Biol Chem; 2000 Jul; 275(29):22435-41. PubMed ID: 10801895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onychin inhibits proliferation of vascular smooth muscle cells by regulating cell cycle.
    Yang M; Huang HL; Zhu BY; Tuo QH; Liao DF
    Acta Pharmacol Sin; 2005 Feb; 26(2):205-11. PubMed ID: 15663900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery.
    Jensen SS; Madsen MW; Lukas J; Binderup L; Bartek J
    Mol Endocrinol; 2001 Aug; 15(8):1370-80. PubMed ID: 11463860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF-I stimulates human intestinal smooth muscle cell growth by regulation of G1 phase cell cycle proteins.
    Kuemmerle JF; Zhou H; Bowers JG
    Am J Physiol Gastrointest Liver Physiol; 2004 Mar; 286(3):G412-9. PubMed ID: 14592948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both estrogen and raloxifene cause G1 arrest of vascular smooth muscle cells.
    Takahashi K; Ohmichi M; Yoshida M; Hisamoto K; Mabuchi S; Arimoto-Ishida E; Mori A; Tsutsumi S; Tasaka K; Murata Y; Kurachi H
    J Endocrinol; 2003 Aug; 178(2):319-29. PubMed ID: 12904179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation.
    Albino AP; Juan G; Traganos F; Reinhart L; Connolly J; Rose DP; Darzynkiewicz Z
    Cancer Res; 2000 Aug; 60(15):4139-45. PubMed ID: 10945621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of MG-63 cell cycle progression by synthetic vitamin D3 analogs mediated by p27, Cdk2, cyclin E, and the retinoblastoma protein.
    Ryhänen S; Jääskeläinen T; Mahonen A; Mäenpää PH
    Biochem Pharmacol; 2003 Aug; 66(3):495-504. PubMed ID: 12907249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta2-adrenergic receptor agonists and cAMP arrest human cultured airway smooth muscle cells in the G(1) phase of the cell cycle: role of proteasome degradation of cyclin D1.
    Stewart AG; Harris T; Fernandes DJ; Schachte LC; Koutsoubos V; Guida E; Ravenhall CE; Vadiveloo P; Wilson JW
    Mol Pharmacol; 1999 Nov; 56(5):1079-86. PubMed ID: 10531416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21(Waf1) and p27(Kip1).
    Marra DE; Simoncini T; Liao JK
    Circulation; 2000 Oct; 102(17):2124-30. PubMed ID: 11044431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.